Kolexia
Bensa Caroline
Neurologie
Fondation Adolphe de Rothschild
Paris, France
93 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sclérose en plaques Sclérose COVID-19 Neuromyélite optique Névrite optique Névrite Sclérose en plaques récurrente-rémittente Maladies démyélinisantes Complications de la grossesse

Industries

Edimark
18 collaboration(s)
Dernière en 2023
Sanofi
15 collaboration(s)
Dernière en 2023
Biogen
11 collaboration(s)
Dernière en 2023
Novartis
10 collaboration(s)
Dernière en 2023

Dernières activités

Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society.
Multiple sclerosis (Houndmills, Basingstoke, England)   15 février 2024
Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES): Evaluation of Biological Response to SARS-COV2 in Patients With Pre-existing Neurological Disease or With New Neurological Manifestations of COVID-19
Essai Clinique (Assistance publique – Hôpitaux de Paris)   01 février 2024
COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022.
Multiple sclerosis (Houndmills, Basingstoke, England)   21 janvier 2024
STOP-I-SEP: Disease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years
Essai Clinique (CHU Rennes)   23 octobre 2023
The radiologically isolated syndrome: revised diagnostic criteria.
Brain : a journal of neurology   03 août 2023
Impact of COVID-19 vaccination or infection on disease activity in a radiologically isolated syndrome cohort: The VaxiRIS study.
Multiple sclerosis (Houndmills, Basingstoke, England)   15 juin 2023
Relevance of kappa free light chains index in patients with aquaporin-4 or myelin-oligodendrocyte-glycoprotein antibodies.
European journal of neurology   03 juin 2023
Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis.
JAMA network open   01 juin 2023
Acute optic neuritis: What are the clues to the aetiological diagnosis in real life?
Multiple sclerosis and related disorders   15 mai 2023
Natalizumab extended-interval dosing in a real-life setting.
Journal of the neurological sciences   13 mai 2023